The table below shows Coya Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$251.15K
$3.56M
$163.62K
$257.88K
$0.00
$3.43M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
-
-
-
-
-
-
SG&A
COYA annual revenue (10-K history)
Coya Therapeutics, Inc. reported annual revenue of $7.95M for fiscal year 2025. That is up 123.6% from $3.55M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.